iRadimed IRMD reported its Q1 earnings results on Thursday, May 4, 2023 at 08:30 AM.
Here's what investors need to know about the announcement.
Earnings
iRadimed beat estimated earnings by 7.14%, reporting an EPS of $0.3 versus an estimate of $0.28.
Revenue was up $3.16 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 2.09% drop in the share price the next day.
Here's a look at iRadimed's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | 0.30 | 0.24 | 0.23 | 0.20 |
EPS Actual | 0.32 | 0.29 | 0.26 | 0.22 |
Revenue Estimate | 14.87M | 13.19M | 12.60M | 12.21M |
Revenue Actual | 14.86M | 13.41M | 12.72M | 12.31M |
To track all earnings releases for iRadimed visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.